RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
April 04, 2024 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 27, 2024 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
February 29, 2024 19:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract...
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 14, 2024 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
January 07, 2024 10:00 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract...
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
December 27, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract...
RxSight, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. Educational and Product Announcements for AAO 2023
November 02, 2023 09:00 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- November 2, 2023 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
October 26, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...